Live Breaking News & Updates on Bern thomas nyang wa
Stay updated with breaking news from Bern thomas nyang wa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies
A combination oral-only therapy of bedaquiline, pretomanid, and linezolid was significantly more effective than standard care in preventing unfavorable outcomes in patients with treatment-resistant tuberculosis.
As one of the winners of the 2022 Stephen Lawn TB–HIV Research Leadership Prize and chief investigator in the trial of a successful oral drug regimen for multidrug-resistant tuberculosis, Bern-Thomas Nyang'wa, Medical Director of the Amsterdam Operational Centre of Médecins Sans Frontières (MSF), has reason to feel pleased. And he is. But he also feels frustrated. As he points out: “We know that close to half a million people [globally] develop drug-resistant tuberculosis every year, but at the moment I don't think even a thousand get the new treatment.” In the light of Nyang'wa and colleagues' research study, WHO revised its guidance on managing multidrug-resistant tuberculosis.
My journey to becoming one of MSF's first black African medical directors "I can’t pretend I’m unaware that I’ll be among the first black Africans who started as local staff to take on the role of MSF medical director. That in itself is a sign of progress, but at the same time, it’s a sign of how far we still have to go." "He believed in me more than I did myself" I was born in Lilongwe in Malawi, the sixth of seven children. My grandfather worked as a doctor and my older sister was a nurse, but growing up, what I most wanted was to play professional basketball.